Skip to main content
Year archive

Sihuan Pharmaceutical Holdings Group Ltd. — 2018 filings

All 39 regulatory filings released by Sihuan Pharmaceutical Holdings Group Ltd. (460) in 2018, sourced directly from the official regulator.

39 Filings
2018 Period
2018 filings (39)
Filing Released Lang
Audit Committee Terms of Reference Adopted by the Board on 8 October, 2010 and Amended by the Board on 19 March 2012 and 31 December 2018
Audit Report / Information
2018-12-31 English
Voluntary Announcement Regarding Compound Electrolyte Injection (II) Sihuan Pharmaceutical Becomes the First Enterprise in China Granted Drug Registration Approval
Regulatory Filings
2018-12-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2018
Share Issue/Capital Change
2018-12-03 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2018-11-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
Regulatory Filings
2018-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
Regulatory Filings
2018-10-02 English
Voluntary Announcement - Metformin Hydrochloride Tablets Obtained Consistency Evaluation Approval (First Generic Product Obtained Approval through Supplementary Application)
Regulatory Filings
2018-10-02 English
Voluntary Announcement - Category 1 Innovative Drug Benapenem Commenced Phase II Clinical Trial in China
Regulatory Filings
2018-09-19 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2018-09-14 English
Notification Letter and Change Request Form to Shareholder
Report Publication Announcement
2018-09-14 English
Interim Report 2018
Interim / Quarterly Report H1 2018
2018-09-14 English
Voluntary Announcement - Rapid-acting Insulin Analogue Insulin Aspart Granted Approval for Clinical Trials
Regulatory Filings
2018-09-10 English
Voluntary Announcement - Long-acting Insulin Degludec Granted Approval for Clinical Trials
Regulatory Filings
2018-09-06 English
Voluntary Announcement - Establishment of Global Business Development Centre
Regulatory Filings
2018-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
Share Issue/Capital Change
2018-09-03 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
Interim / Quarterly Report H1 2018
2018-08-27 English
Voluntary Announcement - Innovative Digestive System Drug Anaprazole Sodium Commenced Phase II Clinical Trial in China
Regulatory Filings
2018-08-20 English
Voluntary Announcement - Pediatric Medicine Midazolam Oromucosal Solution to be Listed in the Priority Review Process
Regulatory Filings
2018-08-16 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-08-15 English
Voluntary Announcement - Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China
Regulatory Filings
2018-08-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2018
Capital/Financing Update
2018-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2018
Regulatory Filings
2018-07-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 1 JUNE 2018 AND DIVIDEND PAYMENT
Declaration of Voting Results & Voting Rights Announcements
2018-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2018
Share Issue/Capital Change
2018-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2018
Capital/Financing Update
2018-05-02 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2018-04-25 English
Notification Letter and Change Request Form to Shareholder
Report Publication Announcement
2018-04-25 English
Form of Proxy for use at Annual General Meeting
AGM Information
2018-04-25 English
Notice of Annual General Meeting
AGM Information
2018-04-25 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-04-25 English
Annual Report 2017
Annual Report FY 2017
2018-04-25 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2018-04-20 English
RESIGNATION AND APPOINTMENT OF DIRECTORS
Board/Management Information
2018-04-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2018
Regulatory Filings
2018-04-03 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
Annual Report FY 2017
2018-03-27 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-03-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2018
Regulatory Filings
2018-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2018
Regulatory Filings
2018-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017
Regulatory Filings
2018-01-02 English